Tumor metastasis: Mechanistic insights and therapeutic interventions

por Liu, Mengmeng, Yang, Jing, Xu, Bushu, Zhang, Xing
Publicado 2021

Comparison of the MAID (AI) and CAV/IE regimens with the predictive value of cyclic AMP-responsive element-binding protein 3 like protein 1 (CREB3L1) in palliative chemotherapy for...

por Xiao, Wei, Liang, Yao, Que, Yi, Li, Jingjing, Peng, Ruiqing, Xu, Bushu, Wen, Xizhi, Zhao, Jingjing, Guan, Yuanxiang, Zhang, Xing
Publicado 2019

LAG-3 expression on tumor-infiltrating T cells in soft tissue sarcoma correlates with poor survival

por Que, Yi, Fang, Zhixin, Guan, Yuanxiang, Xiao, Wei, Xu, Bushu, Zhao, Jingjing, Chen, Huoying, Zhang, Xinke, Zeng, Musheng, Liang, Yao, Zhang, Xing
Publicado 2019

Anlotinib as a maintenance treatment for advanced soft tissue sarcoma after first-line chemotherapy (ALTER-S006): a multicentre, open-label, single-arm, phase 2 trial

por Xu, Bushu, Pan, Qiuzhong, Pan, Hua, Li, Haomiao, Li, Xianan, Chen, Jing, Pang, Danmei, Zhang, Baoqing, Weng, Desheng, Peng, Ruiqing, Fang, Meiyu, Zhang, Xing
Publicado 2023

Phase 1 clinical trial to assess safety and efficacy of NY-ESO-1-specific TCR T cells in HLA-A∗02:01 patients with advanced soft tissue sarcoma

por Pan, Qiuzhong, Weng, Desheng, Liu, Jiayong, Han, Zhaosheng, Ou, Yusheng, Xu, Bushu, Peng, Ruiqing, Que, Yi, Wen, Xizhi, Yang, Jing, Zhong, Shi, Zeng, Lun, Chen, Aiyuan, Gong, Haiping, Lin, Yanmei, Chen, Jiewen, Ma, Ke, Lau, Johnson Y.N., Li, Yi, Fan, Zhengfu, Zhang, Xing
Publicado 2023